Most people prescribed benzodiazephines are unaware that they should only be used for a brief duration and that they can cause dependency and adverse effects even when taken as directed or discontinued. This global health problem has largely been ignored by medicine regulators in all countries.

However, one country, France, has recently launched a new campaign “to raise awareness, among the general public and healthcare professionals, of the dangers of overuse of benzodiazepines which are medicines typically prescribed for the treatment of anxiety and insomnia.”

French health authorities estimate that 40% of people treated with benzodiazepines have prescriptions that offer the drugs for too long. Read the full article at https://www.connexionfrance.com/practical/warning-over-overuse-of-anxiety-and-insomnia-medication-in-france/718550.